FDA Law Blog: Drug Discovery
MARCH 7, 2024
Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.
Drug Target Review
JUNE 6, 2023
Clinical development of IL-18 therapies has been curtailed, however, by the protein’s lack of efficacy. Our vision is the same throughout the clinical development process – bring new options to patients who may need them the most. American Association for Cancer Research; 2006 [cited 2023 Jun 6].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Premier Consulting Blog
JULY 9, 2023
Formally, both of these documents apply solely to marketing approval; informally, however, they are often used as general guidelines during clinical development to avoid obstacles that could result in extensive process changes, product reformulation, or safety qualification efforts. evaluating the safety of) impurities and degradants.
The Pharma Data
OCTOBER 6, 2021
Janssen is now moving its dengue program into clinical development. We look forward to working with our collaborators to accelerate clinical development.”. “As Global Head of Global Public Health R&D at Janssen Research & Development, LLC. Since 2006, Johnson & Johnson has donated more than 1.7
The Pharma Data
FEBRUARY 22, 2022
He began his oncology development career at Rhône Poulenc Rorer Inc. In 1999, he joined the Aventis Group as Senior Director, Oncology Global Clinical Development. In 2005, he was appointed Senior Director of Oncology at Johnson & Johnson and in 2006, Executive Director of Oncology at Schering-Plough.
The Pharma Data
DECEMBER 18, 2020
Roxadustat is also in clinical development for anemia associated with MDS and for chemotherapy-induced anemia. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anaemia in Chronic Kidney Disease. 2006 May; 47(5): S1-S132. Mechanisms of Anemia in CKD. Am J Kidney Dis. Bikbov B et al.
The Pharma Data
OCTOBER 19, 2020
The appointments of Maarten and Teun come at an essential time for AM-Pharma as we finalize all preparations to move into the last stage of clinical development for our lead program,” said Erik van den Berg , Chief Executive Officer at AM-Pharma. USA) from the period of 2006 to 2016. Kenilworth, N.J.,
Expert insights. Personalized for you.
105 
Let's personalize your content